Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix Announces Pricing of Securities Offering
NeuroMetrix Announces Pricing of Securities Offering WALTHAM, Mass. --(BUSINESS WIRE)--Feb. 8, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has priced a public offering of up to 10,500,000 Units at a price per Unit of $1.00 , for aggregate gross proceeds of up to $10,500,000 ,
View HTML
Toggle Summary NeuroMetrix to Present at 5th Annual OneMedForum San Francisco 2012
NeuroMetrix to Present at 5th Annual OneMedForum San Francisco 2012 WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 3, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that Shai N.
View HTML
Toggle Summary NeuroMetrix Reports Commercial Milestone 100th NC-stat® DPNCheck™ Order
NeuroMetrix Reports Commercial Milestone 100th NC-stat® DPNCheck™ Order WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 28, 2011-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced the achievement
View HTML
Toggle Summary NeuroMetrix to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
NeuroMetrix to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 29, 2011-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of
View HTML
Toggle Summary NeuroMetrix Reports Q3 2011 Results
Updates on NC-stat DPNCheck Commercial Launch
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2011 Third Quarter Financial Results Conference Call
NeuroMetrix, Inc. Announces Date for 2011 Third Quarter Financial Results Conference Call WALTHAM, Mass., Oct 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 third quarter financial results before the opening of the market on October 27, 2011.
View HTML
Toggle Summary NeuroMetrix Names Kenneth J. Snow, M.D. as Chief Medical Officer
NeuroMetrix Names Kenneth J. Snow, M.D. as Chief Medical Officer WALTHAM, Mass., Oct 04, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the appointment of Kenneth J. Snow, M.D. as Chief Medical Officer. The appointment was effective October 3, 2011.
View HTML
Toggle Summary NeuroMetrix Reports Compliance With NASDAQ Listing Requirements
NeuroMetrix Reports Compliance With NASDAQ Listing Requirements WALTHAM, Mass., Sep 19, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC ("NASDAQ") indicating that it has regained compliance with the minimum bid
View HTML
Toggle Summary NeuroMetrix Reports Product Milestone
Initiates Commercial Shipments of NC-stat DPNCheck
View HTML
Toggle Summary NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
View HTML